PGIM Jennison Health Sciences Fund - Class R (PJHRX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
30.27
-0.22 (-0.72%)
Mar 13, 2026, 4:00 PM EST
Fund Assets1.46B
Expense Ratio1.48%
Min. Investment$1,000
Turnover81.00%
Dividend (ttm)5.00
Dividend Yield16.52%
Dividend Growth-3.85%
Payout FrequencyAnnual
Ex-Dividend DateDec 19, 2025
Previous Close30.49
YTD Return-6.08%
1-Year Return13.48%
5-Year Return43.92%
52-Week Low27.23
52-Week High38.14
Beta (5Y)n/a
Holdings52
Inception DateFeb 3, 2012

About PJHRX

The PGIM Jennison Health Sciences Fund is a mutual fund focused on achieving long-term capital appreciation by predominantly investing in companies within the healthcare, biotech, and pharmaceutical sectors. This fund targets equity-related securities of U.S. firms involved in industries such as hospitals, health insurance providers, pharmaceutical companies, and medical equipment manufacturers. By concentrating on these sectors, the fund provides a strategic investment opportunity for those interested in the healthcare and biotechnology industries. The fund's high-conviction approach is managed by experienced healthcare specialists, making it a notable player in the financial market for investors seeking exposure to these rapidly evolving sectors.

Fund Family PGIM
Category Health
Performance Rating Above Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol PJHRX
Share Class Class R
Index S&P Composite 1500 Health Care TR

Performance

PJHRX had a total return of 13.48% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.78%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
PHLQXClass R60.77%
PHSZXClass Z0.86%
PHLAXClass A1.13%
PHLCXClass C1.96%

Top 10 Holdings

57.26% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY16.73%
Thermo Fisher Scientific Inc.TMO5.70%
Merck & Co., Inc.MRK5.42%
Danaher CorporationDHR5.22%
Prudential Govt Money Mkt Fdn/a5.05%
Gilead Sciences, Inc.GILD4.96%
UnitedHealth Group IncorporatedUNH4.26%
argenx SEARGX3.44%
Vertex Pharmaceuticals IncorporatedVRTX3.40%
CVS Health CorporationCVS3.09%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 19, 2025$5.00136Dec 19, 2025
Dec 20, 2024$5.20167Dec 20, 2024
Dec 20, 2023$1.91322Dec 20, 2023
Dec 20, 2022$0.61624Dec 20, 2022
Dec 20, 2021$14.02528Dec 20, 2021
Dec 20, 2019$1.43164Dec 20, 2019
Full Dividend History